SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-069746
Filing Date
2015-10-07
Accepted
2015-10-07 17:03:29
Documents
6
Period of Report
2015-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-20861_18k.htm 8-K 39661
2 EX-1.1 a15-20861_1ex1d1.htm EX-1.1 355705
3 EX-4.1 a15-20861_1ex4d1.htm EX-4.1 110271
4 EX-5.1 a15-20861_1ex5d1.htm EX-5.1 12005
5 EX-99.1 a15-20861_1ex99d1.htm EX-99.1 8721
6 EX-99.2 a15-20861_1ex99d2.htm EX-99.2 10383
  Complete submission text file 0001104659-15-069746.txt   537918
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 151149474
SIC: 2834 Pharmaceutical Preparations